We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Live Nation Entertainment
LYV
$39.9B
| $315K | ﹤0.01% |
3,452
+2,626
| +318% | +$205K |
|
1477
Provident Financial
PROV
$115M
| $314K | ﹤0.01% |
24,625
-4,886
| -17% | -$62.2K |
|
|
CVAC
1478
DELISTED
CureVac
CVAC
| $313K | ﹤0.01% |
30,000
-10,000
| -25% | -$89.4K |
|
1479
Campbell Soup
CPB
$6.38B
| $312K | ﹤0.01% |
6,835
+1,180
| +21% | +$60.9K |
|
1480
W.R. Berkley
WRB
$26B
| $312K | ﹤0.01% |
7,860
-540,518
| -99% | -$21.2M |
|
1481
Mirum Pharmaceuticals
MIRM
$6.32B
| $310K | ﹤0.01% |
12,000
| – | – |
|
1482
Mercury Systems
MRCY
$5.25B
| $310K | ﹤0.01% |
8,974
-944,634
| -99% | -$40.3M |
|
|
ZUO
1483
DELISTED
Zuora, Inc.
ZUO
| $308K | ﹤0.01% |
+28,033
| New | +$265K |
|
|
GATO
1484
DELISTED
Gatos Silver, Inc.
GATO
| $302K | ﹤0.01% |
80,000
| – | – |
|
1485
ICF International
ICFI
$1.57B
| $302K | ﹤0.01% |
2,424
-143
| -6% | -$16.5K |
|
1486
Sotera Health
SHC
$5.52B
| $301K | ﹤0.01% |
15,998
-6,550
| -29% | -$104K |
|
1487
Masco
MAS
$13.5B
| $301K | ﹤0.01% |
5,239
+5,179
| +8,632% | +$271K |
|
1488
Ross Stores
ROST
$71.8B
| $298K | ﹤0.01% |
2,656
+834
| +46% | +$87.7K |
|
|
AVB
1489
DELISTED
AvalonBay Communities
AVB
| $296K | ﹤0.01% |
1,564
+18
| +1% | +$3.21K |
|
1490
Air Products & Chemicals
APD
$63.9B
| $295K | ﹤0.01% |
986
-252
| -20% | -$71.8K |
|
|
CBD
1491
DELISTED
Companhia Brasileira de Distribuicao
CBD
| – | – |
0
| – | – |
|
1492
Boston Properties
BXP
$10.2B
| $291K | ﹤0.01% |
5,055
-452,544
| -99% | -$23.5M |
|
|
JBTM
1493
JBT Marel
JBTM
$5.78B
| $290K | ﹤0.01% |
2,389
-160
| -6% | -$17.5K |
|
1494
Orion
OEC
$325M
| $288K | ﹤0.01% |
13,579
-1,507
| -10% | -$36.3K |
|
1495
AES
AES
$10.6B
| $287K | ﹤0.01% |
13,828
-3,581
| -21% | -$78.9K |
|
|
SCWX
1496
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $286K | ﹤0.01% |
39,534
-284,376
| -88% | -$2.36M |
|
1497
Horizon Bancorp
HBNC
$1B
| $283K | ﹤0.01% |
27,221
-1,957
| -7% | -$19.4K |
|
1498
Relmada Therapeutics
RLMD
$450M
| $281K | ﹤0.01% |
+114,124
| New | +$315K |
|
1499
Sensient Technologies
SXT
$5.46B
| $273K | ﹤0.01% |
3,837
-144
| -4% | -$10.7K |
|
1500
C.H. Robinson
CHRW
$17.9B
| $272K | ﹤0.01% |
2,886
+1,368
| +90% | +$132K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.